The reliable derivation of induced pluripotent stem cells (iPSCs) from a noninvasive autologous source at birth would facilitate the study of patient-specific in vitro modeling of congenital diseases and would enhance ongoing efforts aimed at developing novel cell-based treatments for a wide array of fetal and pediatric disorders. Accordingly, we have successfully generated iPSCs from human fetal chorionic somatic cells extracted from term pregnancies by ectopic expression of OCT4, SOX2, KLF4, and cMYC. The isolated parental somatic cells exhibited an immunophenotypic profile consistent with that of chorionic mesenchymal stromal cells (CMSCs). CMSC-iPSCs maintained pluripotency in feeder-free systems for more than 15 passages based on morphology, immunocytochemistry, and gene expression studies and were capable of embryoid body formation with spontaneous trilineage differentiation. CMSC-iPSCs could be selectively differentiated in vitro into various germ layer derivatives, including neural stem cells, beating cardiomyocytes, and definitive endoderm. This study demonstrates the feasibility of term placental chorion as a novel noninvasive alternative to dermal fibroblasts and cord blood for human perinatal iPSC derivation and may provide additional insights regarding the reprogramming capabilities of extra-embryonic tissues as they relate to developmental ontogeny and perinatal tissue engineering applications.
Get full access to this article
View all access options for this article.
References
1.
TakahashiK., and YamanakaS.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663, 2006.
2.
YuJ., VodyanikM.A., Smuga-OttoK., Antosiewicz-BourgetJ., FraneJ.L., TianS., NieJ., JonsdottirG.A., RuottiV., StewartR., SlukvinII, and ThomsonJ.A.Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917, 2007.
SunN., PanettaN.J., GuptaD.M., WilsonK.D., LeeA., JiaF., HuS., CherryA.M., RobbinsR.C., LongakerM.T., and WuJ.C.Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A, 106, 15720, 2009.
5.
GiorgettiA., MontserratN., AasenT., GonzalezF., Rodriguez-PizaI., VassenaR., RayaA., BoueS., BarreroM.J., CorbellaB.A., TorrabadellaM., VeigaA., and Izpisua BelmonteJ.C.Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell, 5, 353, 2009.
6.
JonesG.N., MoschidouD., Puga-IglesiasT.I., KuleszewiczK., VanleeneM., ShefelbineS.J., Bou-GhariosG., FiskN.M., DavidA.L., De CoppiP., and GuillotP.V.Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One, 7, e43395, 2012.
7.
CaiJ., LiW., SuH., QinD., YangJ., ZhuF., XuJ., HeW., GuoX., LabudaK., PeterbauerA., WolbankS., ZhongM., LiZ., WuW., SoK.F., RedlH., ZengL., EstebanM.A., and PeiD.Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem, 285, 11227, 2010.
8.
FujiokaT., ShimizuN., YoshinoK., MiyoshiH., and NakamuraY.Establishment of induced pluripotent stem cells from human neonatal tissues. Hum Cell, 23, 113, 2010.
9.
NazarovI., LeeJ.W., SoupeneE., EtemadS., KnapikD., GreenW., BashkirovaE., FangX., MatthayM.A., KuypersF.A., and SerikovV.B.Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med, 1, 359, 2012.
10.
DominiciM., Le BlancK., MuellerI., Slaper-CortenbachI., MariniF., KrauseD., DeansR., KeatingA., ProckopD., and HorwitzE.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315, 2006.
11.
Villa-DiazL.G., BrownS.E., LiuY., RossA.M., LahannJ., ParentJ.M., and KrebsbachP.H.Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells, 30, 1174, 2012.
12.
BentleyJ.K., PopovaA.P., BozykP.D., LinnM.J., BaekA.E., LeiJ., GoldsmithA.M., and HershensonM.B.Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype. Respir Res, 11, 127, 2010.
13.
ParkI.H., and DaleyG.Q.Human iPS cell derivation/reprogramming. Curr Protoc Stem Cell Biol, Chapter 4, Unit 4A.1, 2009.
14.
Itskovitz-EldorJ., SchuldinerM., KarsentiD., EdenA., YanukaO., AmitM., SoreqH., and BenvenistyN.Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med, 6, 88, 2000.
15.
LivakK.J., and SchmittgenT.D.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402, 2001.
16.
MakS.K., HuangY.A., IranmaneshS., VangipuramM., SundararajanR., NguyenL., LangstonJ.W., and SchuleB.Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int, 2012, 140427, 2012.
17.
ZhangJ., KlosM., WilsonG.F., HermanA.M., LianX., RavalK.K., BarronM.R., HouL., SoerensA.G., YuJ., PalecekS.P., LyonsG.E., ThomsonJ.A., HerronT.J., JalifeJ., and KampT.J.Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res, 111, 1125, 2012.
18.
D'AmourK.A., AgulnickA.D., EliazerS., KellyO.G., KroonE., and BaetgeE.E.Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol, 23, 1534, 2005.
19.
SpenceJ.R., MayhewC.N., RankinS.A., KuharM.F., VallanceJ.E., TolleK., HoskinsE.E., KalinichenkoV.V., WellsS.I., ZornA.M., ShroyerN.F., and WellsJ.M.Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature, 470, 105, 2011.
20.
EstebanM.A., WangT., QinB., YangJ., QinD., CaiJ., LiW., WengZ., ChenJ., NiS., ChenK., LiY., LiuX., XuJ., ZhangS., LiF., HeW., LabudaK., SongY., PeterbauerA., WolbankS., RedlH., ZhongM., CaiD., ZengL., and PeiD.Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 6, 71, 2010.
21.
ParoliniO., AlvianoF., BagnaraG.P., BilicG., BuhringH.J., EvangelistaM., HennerbichlerS., LiuB., MagattiM., MaoN., MikiT., MarongiuF., NakajimaH., NikaidoT., Portmann-LanzC.B., SankarV., SonciniM., StadlerG., SurbekD., TakahashiT.A., RedlH., SakuragawaN., WolbankS., ZeisbergerS., ZischA., and StromS.C.Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells, 26, 300, 2008.
22.
PrasongcheanW., BagniM., CalzarossaC., De CoppiP., and FerrettiP.Amniotic fluid stem cells increase embryo survival following injury. Stem Cells Dev, 21, 675, 2012.
23.
MaciasM.I., GrandeJ., MorenoA., DominguezI., BornsteinR., and FloresA.I.Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol, 203, 495 e9, 2010.
24.
YeL., ChangJ.C., LinC., SunX., YuJ., and KanY.W.Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A, 106, 9826, 2009.
25.
LiC., ZhouJ., ShiG., MaY., YangY., GuJ., YuH., JinS., WeiZ., ChenF., and JinY.Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet, 18, 4340, 2009.
26.
GalendeE., KarakikesI., EdelmannL., DesnickR.J., KerenyiT., KhoueiryG., LaffertyJ., McGinnJ.T., BrodmanM., FusterV., HajjarR.J., and PolgarK.Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram, 12, 117, 2010.
27.
ZhaoH.X., LiY., JinH.F., XieL., LiuC., JiangF., LuoY.N., YinG.W., WangJ., LiL.S., YaoY.Q., and WangX.H.Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG. Differentiation, 80, 123, 2010.
28.
LiuP., ChenS., LiX., QinL., HuangK., WangL., HuangW., LiS., JiaB., ZhongM., PanG., CaiJ., and PeiD.Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells. PLoS One, 8, e69617, 2013.
29.
BiebackK., and BrinkmannI.Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells, 2, 81, 2010.
30.
KernS., EichlerH., StoeveJ., KluterH., and BiebackK.Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294, 2006.
31.
LohY.H., HartungO., LiH., GuoC., SahalieJ.M., ManosP.D., UrbachA., HeffnerG.C., GrskovicM., VigneaultF., LenschM.W., ParkI.H., AgarwalS., ChurchG.M., CollinsJ.J., IrionS., and DaleyG.Q.Reprogramming of T cells from human peripheral blood. Cell Stem Cell, 7, 15, 2010.
32.
KimK., ZhaoR., DoiA., NgK., UnternaehrerJ., CahanP., HuoH., LohY.H., AryeeM.J., LenschM.W., LiH., CollinsJ.J., FeinbergA.P., and DaleyG.Q.Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol, 29, 1117, 2011.
33.
FauzaD.Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol, 18, 877, 2004.
34.
TitomanlioL., KavelaarsA., DalousJ., ManiS., El GhouzziV., HeijnenC., BaudO., and GressensP.Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol, 70, 698, 2011.
35.
BailoM., SonciniM., VertuaE., SignoroniP.B., SanzoneS., LombardiG., ArientiD., CalamaniF., ZattiD., PaulP., AlbertiniA., ZorziF., CavagniniA., CandottiF., WenglerG.S., and ParoliniO.Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation, 78, 1439, 2004.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
